Drug Type Interleukins |
Synonyms- |
Target |
Mechanism IL-2 stimulants(Interleukin-2 stimulants), Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Phase 2 | - | - |
Phase 1/2 | Renal Cell Carcinoma Maintenance | 12 | IL-2N | dhdkrijlbb(qtpojtwlys) = gdxdeijuml gggcrgyrfa (bxmgqrsxxs ) | - | 20 Jun 2006 | |
IL-2XL | dhdkrijlbb(qtpojtwlys) = qivqckvhmr gggcrgyrfa (bxmgqrsxxs ) |